Rhythm Pharmaceuticals (RYTM) Current Leases (2019 - 2025)
Historic Current Leases for Rhythm Pharmaceuticals (RYTM) over the last 7 years, with Q3 2025 value amounting to $624000.0.
- Rhythm Pharmaceuticals' Current Leases changed N/A to $624000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $624000.0, marking a year-over-year change of. This contributed to the annual value of $770000.0 for FY2023, which is 1257.31% up from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Current Leases stood at $624000.0 for Q3 2025.
- Rhythm Pharmaceuticals' Current Leases' 5-year high stood at $816000.0 during Q2 2024, with a 5-year trough of $224000.0 in Q1 2025.
- Moreover, its 5-year median value for Current Leases was $644000.0 (2022), whereas its average is $638235.3.
- As far as peak fluctuations go, Rhythm Pharmaceuticals' Current Leases surged by 1355.24% in 2021, and later crashed by 7175.28% in 2025.
- Quarter analysis of 5 years shows Rhythm Pharmaceuticals' Current Leases stood at $606000.0 in 2021, then rose by 12.87% to $684000.0 in 2022, then rose by 12.57% to $770000.0 in 2023, then grew by 5.97% to $816000.0 in 2024, then decreased by 23.53% to $624000.0 in 2025.
- Its Current Leases stands at $624000.0 for Q3 2025, versus $510000.0 for Q2 2025 and $224000.0 for Q1 2025.